Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NOR-CACTUS Trial: Injection vs Surgery for Carpal Tunnel Syndrome
NCT05306548Phase 4Active, not recruiting
- Sponsor
- Diakonhjemmet Sykehus
- Start
- Apr 2022
- Primary completion
- Mar 2027
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in carpal tunnel syndrome (CTS) (2 arms), sponsored by Diakonhjemmet Sykehus. Primary endpoint: Successful treatment result at 24 months. Started Apr 2022; status: active, not recruiting.
02
Conditions
carpal tunnel syndrome (CTS)
Beyond the preview
Go deeper on NCT05306548.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05306548.